Biotechnology
DNA vaccination is a promising approach for generating immune responses, particularly cell-mediated immune response, in various species. However, its efficacy is often limited by relatively weak immune responses. Researchers in China have investigated the effects of several chemical adjuvants on DNA vaccination, including levamisole, Tween 80, and bupivacaine. Their findings
Biotechnology
A study conducted by P.Q. Ye and colleagues from the University of Washington's Department of Pediatrics has found that the transfer of factor VIII DNA in mice stimulates the production of anti-transgene antibodies, potentially limiting the success of human gene therapy approaches. The researchers inserted factor VIII
Biotechnology
Researchers from the United States have made a significant discovery in the field of vaccine development with the review of the immunobiology of the Tomatine adjuvant in a recent issue of the journal Vaccine. According to the study, soluble or sub-unit protein vaccines alone are incapable of generating antigen-specific cellular
Biotechnology
According to a study published in Vaccine, researchers from Australia have found that ISCOMATRIX adjuvant is capable of inducing broad and potent humoral and cellular immune responses. The study, led by Martin J. Pearse and D. Drane at CSL Ltd, highlights the potential of ISCOMATRIX adjuvant in vaccine development, particularly
Cytology
Researchers in Brazil have developed an in situ enzyme immunoassay that can monitor the growth of hepatitis A virus in cell culture. This assay is a significant improvement over the traditional radioimmunofocus assay, which is labor-intensive and requires the use of radioisotopes. The new assay uses a peroxidase-labeled polyclonal antibody
Cytology
Scientists in the United States have reported a significant breakthrough in HIV-1 vaccine research. A novel anionic nanoparticle coated with the HIV-1 Tat(1-72) protein was found to generate strong T cell type-1 immune responses in mice. This finding is promising for the development of HIV-1 vaccines, as Tat(1-72)
Immunology
Researchers from France have demonstrated that Toxoplasma gondii antigen-pulsed dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. This novel cell-free vaccine, composed of DC exosomes, has shown promise in eliciting a systemic Th1-biased specific immune response and conferring protection against infection. The study highlights the potential
Immunology
Scientists in Italy have reported the occurrence of spontaneous mutations in the constant regions of T-cell receptor beta chains of T lymphocytes obtained from two babies who underwent in utero stem cell transplantation due to severe combined immunodeficiency. The study found that hypermutation of the T-cell receptor genes may occur
Immunology
Researchers have identified differences in the immune response elicited by liposome adjuvants prepared from various bacteria, including Haloferax volcanii, Planococcus species, and Bacillus firmus. The study, published in the journal Vaccine, found that liposomes from Haloferax volcanii were more effective in sustaining antigen-specific T cell immunity compared to those from
Immunology
Researchers at Antigen Express, a subsidiary of Generex Biotechnology Corp., have made significant advancements in cancer immunotherapy with the development of novel peptide vaccines. At the 12th International Congress of Immunology and the 4th annual conference of FOCIS in Montreal, Quebec, Cathy Blackwell presented a research abstract titled "Enhanced
Communicable diseases
The study aimed to assess the impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. The research involved 13 volunteers who were preimmunized with Salmonella Typhi Ty21a and then received doses of
Immunology
Scientists have discovered that HIV-1 genomes reside within actively transcribed host genes in resting CD4+ T cells, a finding that challenges the conventional understanding of HIV-1 gene expression. The study, published in the Journal of Virology, revealed that 93% of HIV-1 integration sites in resting CD4+ T cells from patients
